The objective of this study was to develop and test a combined therapeutic approach for patients with AIDS-related lymphoma (ARL), employing agents with independent mechanisms of action and nonoverlapping toxicity. This study was designed to test the feasibility and tolerance of combining low dose c
AIDS-related non-Hodgkin's lymphomas
β Scribed by John Krause
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 664 KB
- Volume
- 68
- Category
- Article
- ISSN
- 1059-910X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
This work reviews the current status of nonβHodgkin's lymphoma (NHL) in HIV infected patients. HIV infection remains at significantly increased risk for the development of NHL. The great majority of these lymphomas are highβgrade monoclonal Bβcell neoplasms often occurring in unusual sites. A number of genetic abnormalities have been found but additional studies are necessary to understand the etiology and pathogenesis of NHL in the setting of HIV infection. The cases in this paper have been seen on the Hematopathology service of the Tulane Health Sciences Center. Microsc. Res. Tech. 68:168β175, 2005. Β© 2005 WileyβLiss, Inc.
π SIMILAR VOLUMES
Although cardiac involvement has been commonly described in HIV-infected patients, cardiac tamponade is an unusual feature of AIDS-related non-Hodgkin's lymphoma. We describe an AIDS patient with undiagnosed non-Hodgkin's lymphoma presenting with hemodynamics of pericardial tamponade.
Although it is well known that the risk of non-Hodgkin's lymphoma (NHL) is elevated significantly after treatment for Hodgkin's disease,' an increased risk of Hodgkin's disease following NHL has not been noted in several large cancer registry Although descriptions of Hodgkin's disease following NHL